Focusing in on historical stock price information for BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), we can see that over the last 52-week period the high point is 9.2. Over the same period, the lowest that the stock has touched is 2.66. If we take a look at current stock price levels as a percentage of the 52 week high/low range, we can see that shares have a value of 41.59. This value is an indicator of the stock’s position within the 52-week trading range. A value of 0 would indicate that shares are currently trading at the 52-week low. On the other end of the spectrum, a value of 100 would indicate that shares are currently trading at the 52-week high. Investors typically pay increased attention to stocks that are nearing either the 52-week high or 52-week low mark.
Over the past week, BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) shares have seen a price percentage change of -2.36. Looking back over the past 4 weeks, shares have seen a percentage change of -3.93. If we scroll back to the price percentage change since the start of the calendar year, we can see that shares are -15.01. Going back a period of 12 weeks, we can see that shares have changed -35.65. Investors often look to the beta in order to measure risk by comparing a stock’s volatility to that of the overall market. The stock currently has a beta value of 3.43. Stocks with a beta value over 1 have historically been more volatile than the overall market. Stocks that have a beta value under 1 have historically been less volatile than the overall market.
We can also take a look at the relative price change value for the stock. Currently, this value is spotted at -21.67. Using the year-to-date time frame, this value is calculated by comparing the individual change in stock price to the price change of the S&P 500 index over that same period. If the stock has a value of 1, it would indicate that the price change is equivalent to that of the S&P 500 during the period. A negative value would indicate that the stock has underperformed, and a positive value would indicate that shares have outperformed the S&P 500 index over the specified time-frame.
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) currently has a value score of F. This score ranks stocks based on various valuation metrics. The goal of the score is to separate stocks that are overvalued with those that may be temporarily undervalued. The score uses values of A, B, C, D, and F, where an A score would be the best, and a score of F would be seen as the opposite. The stock presently has a growth score of F. This score evaluates earnings and sales growth along with other various aspects of the income statement, balance sheet, and cash flow statement. The growth score assigns an A,B,C,D, or F. Here, a score of A would represent the highest score, and a score of F would indicate the lowest score.